EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Clinical trial NCT06011772 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06011772
- Sponsor
- Roswell Park Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-18
- Primary completion
- 2026-02-05
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.